Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000156939 | SCV003443317 | pathogenic | Glycogen storage disease, type II | 2023-07-11 | criteria provided, single submitter | clinical testing | This missense change has been observed in individual(s) with Pompe disease (PMID: 32711049). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Gly335 amino acid residue in GAA. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 22644586, 31510962). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Experimental studies have shown that this missense change affects GAA function (PMID: 22644586). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GAA protein function. ClinVar contains an entry for this variant (Variation ID: 180142). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 335 of the GAA protein (p.Gly335Glu). |
Medical Genetic Department, |
RCV000156939 | SCV000206660 | pathogenic | Glycogen storage disease, type II | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001579766 | SCV001808447 | likely pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001579766 | SCV001964592 | pathogenic | not provided | no assertion criteria provided | clinical testing |